Kazumi Fujikawa, Takeda Pharmaceuticals
Kazumi Fujikawa, VP, Market Data Management, Global Commercial, Takeda Pharmaceuticals (Japan)
Kazumi is well known in the “Insights professional circle” for her distinguished experience that includes global, regional and local roles for various multinational corporations: Pfizer, IMS, Sanofi-Aventis and has covered a range of responsibilities in her previous life that includes Product commercialization Strategy, Market Research and Analytic to logistics.
She holds BA of English Literature, Nortre Dame Seishin University, Japan and holds MBA, Marketing from Leicester University, UK. She is certified, leadership and organization development from New York University and is certified of MBTI instructor from American Management Association.
She is a key contributor of creating Steering Committee of Japan Market Research Association. She has several publications related to market research and pharmaceutical marketing.
Sundeep Lal, Medtronic
Sundeep Lal, Vice President, Business Development, Strategy and Healthcare Solutions, Asia Pacific, Medtronic (Singapore)
Dr. Sundeep Lal is Vice President of Strategy, Business Development and Business Model Innovation for Medtronic. Sundeep has over twenty years of healthcare experience in pharmaceutical, bio-tech and med-tech industries in US and Emerging Markets. At Medtronic, Sundeep collaborates with Asian regional and country leaders and teams to create country specific organic and inorganic growth strategies and their execution plans. Passionate about creating innovative healthcare delivery models for solving affordability, access and awareness barriers in Emerging Markets, Sundeep is building Medtronic’s Global Business Model Innovation and “Solution and Services” capabilities to address such market specific challenges.
Prior to Medtronic, Sundeep was with Merck based out of Whitehouse Station, NJ. In eleven years with Merck, Sundeep utilized strategic insights to create transformational growth platforms through business development such as acquisition of Schering-Plough (Global), Sun and Simcere Pharma JV’s (Emerging Markets and China) and numerous early and late stage global R&D in-licensing programs. Sundeep’s last role at Merck was as Executive Director and Head of Business Development for Emerging Markets, where he was the key architect of Merck’s strategy for expansion into EM’s through differentiated BGx’s.
A Cornell MBA, Sundeep’s, prior background includes role as a management consultant as well a discovery research scientist. Sundeep has a Ph.D. in Chemistry from University of Louisville where he was a University Fellow and a B.Sc. (Honors) from University of Delhi, India. Sundeep’s work has led to start up of one biotech company, 1 patent and over 15 refereed publications. Most recently, his work has been profiled in HBR and Forbes. Sundeep serves on the board of International Partnership for Innovative Healthcare Delivery, Investment Committee Observer for Quadria Capital and an invitee to Evaluation Panel for Singapore Govt’s startup investments. Sundeep has working and living experiences in US and Asia.
Nobuo Murakami, Daiichi Sankyo
Nobuo Murakami, Senior Director, Daiichi Sankyo
Noriko Nishi, Shionogi & Co.
Noriko Nishi, Vice President and Head of Global New Product Planning, Global Development, Shionogi & Co., Ltd.
Etsuyo Ogawa, Bayer Yakuhin, Ltd.
Etsuyo Ogawa, Head of Commercial Insights & Analytics Japan, Bayer Yakuhin, Ltd.
Etsuyo Ogawa is the Head of Commercial Insights & Analytics Japan at Bayer Yakuhin, Ltd. Etsuyo is responsible for primary market research, forecasting, secondary data management and advanced analytics.
After graduating from Mie University, Estuyo started her career as a Medical Partner in charge of the university hospital at Ciba Geigy (currently Novartis). Following that, she worked as the creative director at Graphic International, where she developed promotion plans and materials for the launches of new major medical device/clinical diagnostic clients. After that, she joined Nihon Schering in April 1991 and worked for various assignments such as Marketing, Marketing intelligence, Strategy Planning, Pricing/External Affairs, e-marketing and HEOR, taking on increased responsibilities until Bayer acquired Nihon Schering in July 2007.
She has excellent problem solving skills, is specialized in marketing pharmaceuticals in Japan, and enjoys working in a flexible, fast-paced environment.
Pascal Qian, Novartis
Pascal Qian, Executive Director, Head of Solid Tumors, Novartis (China)
Veronique Toully, UCB
Veronique Toully, Managing Director, China, UCB (China)
Yan Zhang, Roche
Yan Zhang, Vice President, Strategic Planning and Commercial Excellence, Roche (China)
Yan started and has been with Genentech for 13 years and held various leadership roles in Forecasting & Business Analysis and Market Planning. From January 2013, she takes on new role in Roche Shanghai to lead six functional teams including Sales Force Effectiveness, Commercial Training & Development, Strategic Planning, Program Management, e-Marketing, and Event Operation Team. Prior to Genentech, she worked at McKinsey & Company and conducted drug discovery research at Syntex Pharmaceutical. She holds Bachelor’s degree from Peking University and her Ph.D. in Bio-physical Chemistry from Stanford University.